Cargando…
Fasciola hepatica Cathepsin L Zymogens: Immuno-Proteomic Evidence for Highly Immunogenic Zymogen-Specific Conformational Epitopes to Support Diagnostics Development
[Image: see text] Fasciola hepatica, the common liver fluke and causative agent of zoonotic fasciolosis, impacts on food security with global economic losses of over $3.2 BN per annum through deterioration of animal health, productivity losses, and livestock death and is also re-emerging as a foodbo...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361350/ https://www.ncbi.nlm.nih.gov/pubmed/35849550 http://dx.doi.org/10.1021/acs.jproteome.2c00299 |
_version_ | 1784764513880375296 |
---|---|
author | Collett, Clare F. Phillips, Helen C. Fisher, Maggie Smith, Sian Fenn, Caroline Goodwin, Phil Morphew, Russell M. Brophy, Peter M. |
author_facet | Collett, Clare F. Phillips, Helen C. Fisher, Maggie Smith, Sian Fenn, Caroline Goodwin, Phil Morphew, Russell M. Brophy, Peter M. |
author_sort | Collett, Clare F. |
collection | PubMed |
description | [Image: see text] Fasciola hepatica, the common liver fluke and causative agent of zoonotic fasciolosis, impacts on food security with global economic losses of over $3.2 BN per annum through deterioration of animal health, productivity losses, and livestock death and is also re-emerging as a foodborne human disease. Cathepsin proteases present a major vaccine and diagnostic target of the F. hepatica excretory/secretory (ES) proteome, but utilization in diagnostics of the highly antigenic zymogen stage of these proteins is surprisingly yet to be fully exploited. Following an immuno-proteomic investigation of recombinant and native procathepsins ((r)FhpCL1), including mass spectrometric analyses (DOI: 10.6019/PXD030293), and using counterpart polyclonal antibodies to a recombinant mutant procathepsin L (anti-rFhΔpCL1), we have confirmed recombinant and native cathepsin L zymogens contain conserved, highly antigenic epitopes that are conformationally dependent. Furthermore, using diagnostic platforms, including pilot serum and fecal antigen capture enzyme-linked immunosorbent assay (ELISA) tests, the diagnostic capacities of cathepsin L zymogens were assessed and validated, offering promising efficacy as markers of infection and for monitoring treatment efficacy. |
format | Online Article Text |
id | pubmed-9361350 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-93613502022-08-10 Fasciola hepatica Cathepsin L Zymogens: Immuno-Proteomic Evidence for Highly Immunogenic Zymogen-Specific Conformational Epitopes to Support Diagnostics Development Collett, Clare F. Phillips, Helen C. Fisher, Maggie Smith, Sian Fenn, Caroline Goodwin, Phil Morphew, Russell M. Brophy, Peter M. J Proteome Res [Image: see text] Fasciola hepatica, the common liver fluke and causative agent of zoonotic fasciolosis, impacts on food security with global economic losses of over $3.2 BN per annum through deterioration of animal health, productivity losses, and livestock death and is also re-emerging as a foodborne human disease. Cathepsin proteases present a major vaccine and diagnostic target of the F. hepatica excretory/secretory (ES) proteome, but utilization in diagnostics of the highly antigenic zymogen stage of these proteins is surprisingly yet to be fully exploited. Following an immuno-proteomic investigation of recombinant and native procathepsins ((r)FhpCL1), including mass spectrometric analyses (DOI: 10.6019/PXD030293), and using counterpart polyclonal antibodies to a recombinant mutant procathepsin L (anti-rFhΔpCL1), we have confirmed recombinant and native cathepsin L zymogens contain conserved, highly antigenic epitopes that are conformationally dependent. Furthermore, using diagnostic platforms, including pilot serum and fecal antigen capture enzyme-linked immunosorbent assay (ELISA) tests, the diagnostic capacities of cathepsin L zymogens were assessed and validated, offering promising efficacy as markers of infection and for monitoring treatment efficacy. American Chemical Society 2022-07-18 2022-08-05 /pmc/articles/PMC9361350/ /pubmed/35849550 http://dx.doi.org/10.1021/acs.jproteome.2c00299 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Collett, Clare F. Phillips, Helen C. Fisher, Maggie Smith, Sian Fenn, Caroline Goodwin, Phil Morphew, Russell M. Brophy, Peter M. Fasciola hepatica Cathepsin L Zymogens: Immuno-Proteomic Evidence for Highly Immunogenic Zymogen-Specific Conformational Epitopes to Support Diagnostics Development |
title | Fasciola hepatica Cathepsin
L Zymogens: Immuno-Proteomic Evidence for Highly Immunogenic Zymogen-Specific
Conformational Epitopes to Support Diagnostics Development |
title_full | Fasciola hepatica Cathepsin
L Zymogens: Immuno-Proteomic Evidence for Highly Immunogenic Zymogen-Specific
Conformational Epitopes to Support Diagnostics Development |
title_fullStr | Fasciola hepatica Cathepsin
L Zymogens: Immuno-Proteomic Evidence for Highly Immunogenic Zymogen-Specific
Conformational Epitopes to Support Diagnostics Development |
title_full_unstemmed | Fasciola hepatica Cathepsin
L Zymogens: Immuno-Proteomic Evidence for Highly Immunogenic Zymogen-Specific
Conformational Epitopes to Support Diagnostics Development |
title_short | Fasciola hepatica Cathepsin
L Zymogens: Immuno-Proteomic Evidence for Highly Immunogenic Zymogen-Specific
Conformational Epitopes to Support Diagnostics Development |
title_sort | fasciola hepatica cathepsin
l zymogens: immuno-proteomic evidence for highly immunogenic zymogen-specific
conformational epitopes to support diagnostics development |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361350/ https://www.ncbi.nlm.nih.gov/pubmed/35849550 http://dx.doi.org/10.1021/acs.jproteome.2c00299 |
work_keys_str_mv | AT collettclaref fasciolahepaticacathepsinlzymogensimmunoproteomicevidenceforhighlyimmunogeniczymogenspecificconformationalepitopestosupportdiagnosticsdevelopment AT phillipshelenc fasciolahepaticacathepsinlzymogensimmunoproteomicevidenceforhighlyimmunogeniczymogenspecificconformationalepitopestosupportdiagnosticsdevelopment AT fishermaggie fasciolahepaticacathepsinlzymogensimmunoproteomicevidenceforhighlyimmunogeniczymogenspecificconformationalepitopestosupportdiagnosticsdevelopment AT smithsian fasciolahepaticacathepsinlzymogensimmunoproteomicevidenceforhighlyimmunogeniczymogenspecificconformationalepitopestosupportdiagnosticsdevelopment AT fenncaroline fasciolahepaticacathepsinlzymogensimmunoproteomicevidenceforhighlyimmunogeniczymogenspecificconformationalepitopestosupportdiagnosticsdevelopment AT goodwinphil fasciolahepaticacathepsinlzymogensimmunoproteomicevidenceforhighlyimmunogeniczymogenspecificconformationalepitopestosupportdiagnosticsdevelopment AT morphewrussellm fasciolahepaticacathepsinlzymogensimmunoproteomicevidenceforhighlyimmunogeniczymogenspecificconformationalepitopestosupportdiagnosticsdevelopment AT brophypeterm fasciolahepaticacathepsinlzymogensimmunoproteomicevidenceforhighlyimmunogeniczymogenspecificconformationalepitopestosupportdiagnosticsdevelopment |